Loading insider details...
Beta
Latest Form 4 (Jul 8, 2026): Grant/Award of 1,106 NAGE shares, $3.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 8, 2026 | Niagen Bioscience, Inc. (NAGE) | Grant/Award | 1,106 | $3.0K |
| Apr 27, 2026 | Niagen Bioscience, Inc. (NAGE) | Exercise/Conversion | 20,000 | $52.2K |
| Feb 24, 2026 | Niagen Bioscience, Inc. (NAGE) | Grant/Award | 503,937 | n/a |
| Apr 9, 2025 | Niagen Bioscience, Inc. (NAGE) | Exercise/Conversion | 66,667 | $220.0K |
| Feb 27, 2025 | ChromaDex Corp. (CDXC) | Grant/Award | 1,518,600 | n/a |
| Feb 14, 2025 | ChromaDex Corp. (CDXC) | Grant/Award | 492,278 | n/a |
| Feb 24, 2024 | ChromaDex Corp. (CDXC) | Grant/Award | 399,568 | n/a |
| Jun 1, 2023 | ChromaDex Corp. (CDXC) | Purchase | 7,000 | $9.9K |
| Feb 17, 2023 | ChromaDex Corp. (CDXC) | Grant/Award | 306,366 | n/a |
| Oct 4, 2022 | ChromaDex Corp. (CDXC) | Purchase | 80,000 | $100.0K |